Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute
Primary Purpose
Diarrhea, Children
Status
Unknown status
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Zinc group
Placebo group
Sponsored by
About this trial
This is an interventional treatment trial for Diarrhea focused on measuring zinc, Duration
Eligibility Criteria
Inclusion Criteria:
- Patients 6 months to 5 years old with acute diarrhea
- Patients in their first 48 hours of onset diarrhea
- Dehydration mild to moderate according to WHO clinical scale
- Both sexes
- Outpatients
Exclusion Criteria:
- Patients with vomit (10 or more)
- Hemodynamic Instability
- Severe dehydration
- Patients with heart disease
- Patients with a history of prematurity.
- Patients with chronic diarrhea
- Patients whose parents refuse to provide written informed consent
- Patients who do not comply with treatment correctly
- Patients with suspected surgical pathology
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Zinc group
Placebo group
Arm Description
Pedialyte diarrhea oral electrolyte solution, 330 ml per day for 7 days
Pedialyte oral electrolyte solution, 330 ml per day for 7 days
Outcomes
Primary Outcome Measures
Number of bowel movements per day
Secondary Outcome Measures
Full Information
NCT ID
NCT02601742
First Posted
November 9, 2015
Last Updated
November 9, 2015
Sponsor
Hospital General Naval de Alta Especialidad - Escuela Medico Naval
1. Study Identification
Unique Protocol Identification Number
NCT02601742
Brief Title
Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute
Official Title
Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute in Mexican Children: Randomized Double-blind Study
Study Type
Interventional
2. Study Status
Record Verification Date
October 2015
Overall Recruitment Status
Unknown status
Study Start Date
November 2015 (undefined)
Primary Completion Date
January 2016 (Anticipated)
Study Completion Date
November 2016 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital General Naval de Alta Especialidad - Escuela Medico Naval
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Acute diarrhea is the third cause of infant mortality in the world causing 15% of all deaths in children under 5 years and is responsible for nearly 1.4 million deaths in developing countries. It is considered a self-limiting disease and to this problem the recommendation of the World Health Organization (WHO) is the administration of zinc with low osmolarity oral dehydration salts for a period of 10-14 days which reduces the severity of the episode.
In Mexico COFEPRIS believes the zinc salt as a food supplement and not a drug and the above problem is presented in terms of prescribing and access of this salt to the general population. In Mexico the investigators have the provision and accessibility of low osmolarity oral dehydration salts supplemented with adequate doses of zinc, which is inexpensive for the general population and offering a solution in terms of supply and management.
The purpose of the study involves the evaluation Pedialyte diarrhea in the treatment of acute diarrhea in children under 5 years. The investigator sconsider the use of Pedialyte diarrhea eases their access to the population in general and it is low cost compared with the zinc salt that is sold only in specialized pharmacies under strict medical prescription Objective: Compare the duration of symptoms of acute diarrhea in the treatment with low osmolarity oral rehydration salts (Pedialyte) vs treatment of low osmolarity oral rehydration supplemented with zinc (Pedialyte diarrhea) Study Desing: Double blind, randomized, controlled.
Detailed Description
It will be conducted a randomized controlled double-blind in the Emergency service of the Naval General Hospital of High Specialty in the Mexico City. The period of patient inclusion in the study is October 2015 to November 2016.
The patients selections is the children between 6 months and 5 years who come to the emergency room with symptoms of acute diarrhea with up to 48 hours of starting the disease, it will proceed to questioning and to assess vital signs and thorough physical examination for determine the degree of dehydration, nutritional status and rule out diagnosis of abdominal pathology emergency.
Selection criteria Inclusion
Patients 6 months to 5 years old with acute diarrhea
Patients in their first 48 hours of onset diarrhea
Dehydration mild to moderate according to WHO clinical scale
Both sexes
Outpatients
Exclusion
Patients with vomit (10 or more)
Hemodynamic Instability
Dehydration severe
Patients with heart disease
Patients with a history of prematurity.
Patients with chronic diarrhea
Patients whose parents refuse to provide written informed consent
Patients who do not comply with treatment correctly
Patients with suspected surgical pathology
Elimination
Patients with severe dehydration
Patients in whom the parents decline for informed consent
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diarrhea, Children
Keywords
zinc, Duration
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
350 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Zinc group
Arm Type
Active Comparator
Arm Description
Pedialyte diarrhea oral electrolyte solution, 330 ml per day for 7 days
Arm Title
Placebo group
Arm Type
Placebo Comparator
Arm Description
Pedialyte oral electrolyte solution, 330 ml per day for 7 days
Intervention Type
Other
Intervention Name(s)
Zinc group
Other Intervention Name(s)
Pedialyte diarrhea 45
Intervention Description
Pedialyte diarrhea oral electrolyte solution, 330 ml per day for 7 days
Intervention Type
Other
Intervention Name(s)
Placebo group
Other Intervention Name(s)
Pedialyte SR 45
Intervention Description
Pedialyte oral electrolyte solution, 330 ml per day for 7 days
Primary Outcome Measure Information:
Title
Number of bowel movements per day
Time Frame
4 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients 6 months to 5 years old with acute diarrhea
Patients in their first 48 hours of onset diarrhea
Dehydration mild to moderate according to WHO clinical scale
Both sexes
Outpatients
Exclusion Criteria:
Patients with vomit (10 or more)
Hemodynamic Instability
Severe dehydration
Patients with heart disease
Patients with a history of prematurity.
Patients with chronic diarrhea
Patients whose parents refuse to provide written informed consent
Patients who do not comply with treatment correctly
Patients with suspected surgical pathology
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
María del Carmen Yebra Cano, Medicina
Phone
5585315297
Email
melitacar@hotmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
María del Carmen Yebra Cano, Medicina
Organizational Affiliation
Secretaria de Marina-Armada de México (Mexican Navy)
Official's Role
Principal Investigator
12. IPD Sharing Statement
Citations:
PubMed Identifier
22579125
Citation
Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012 Jun 9;379(9832):2151-61. doi: 10.1016/S0140-6736(12)60560-1. Epub 2012 May 11. Erratum In: Lancet. 2012 Oct 13;380(9850):1308.
Results Reference
background
PubMed Identifier
22682449
Citation
Gupta GR. Tackling pneumonia and diarrhoea: the deadliest diseases for the world's poorest children. Lancet. 2012 Jun 9;379(9832):2123-4. doi: 10.1016/S0140-6736(12)60907-6. No abstract available.
Results Reference
background
Citation
Aurelio Mejia y cosl., Analisis de costo beneficio de la suplementación con Zinc en el tratamiento de la diarrea aguda en niños menores de 5 años en Colombia, publicado en ESPGHAN 2015
Results Reference
background
Citation
Scrimgeour, A.; Condlin, M.; Otieno, L.; Bovill, M. Zinc intervention strategies: Costs and health benefits. In Nutrients, Dietary Supplements, and Nutriceuticals; Gerald, J.K., Watson, R.R., Preedy, V.R., Eds.; Humana Press: 201
Results Reference
background
Citation
WHO/UNICEF. Joint Statement on the Clinical Management of Acute Diarrhoea; UNICEF: 2004
Results Reference
background
Citation
Benguigui Y, Bernal C, Figueroa D, eds. Manual de Tratamiento de la Diarrea en Nin˜os. Washington, DC: Panamerican Health Organization/ Organización Panamericana de la Salud; 2008
Results Reference
background
PubMed Identifier
16740827
Citation
Malek MA, Curns AT, Holman RC, Fischer TK, Bresee JS, Glass RI, Steiner CA, Parashar UD. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics. 2006 Jun;117(6):1887-92. doi: 10.1542/peds.2005-2351.
Results Reference
background
PubMed Identifier
16541699
Citation
Majowicz SE, McNab WB, Sockett P, Henson TS, Dore K, Edge VL, Buffett MC, Fazil A, Read S, McEwen S, Stacey D, Wilson JB. Burden and cost of gastroenteritis in a Canadian community. J Food Prot. 2006 Mar;69(3):651-9. doi: 10.4315/0362-028x-69.3.651.
Results Reference
background
PubMed Identifier
22696352
Citation
Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev. 2012 Jun 13;(6):CD005436. doi: 10.1002/14651858.CD005436.pub3.
Results Reference
background
PubMed Identifier
25176404
Citation
Liberato SC, Singh G, Mulholland K. Zinc supplementation in young children: A review of the literature focusing on diarrhoea prevention and treatment. Clin Nutr. 2015 Apr;34(2):181-8. doi: 10.1016/j.clnu.2014.08.002. Epub 2014 Aug 13.
Results Reference
background
Citation
Dr Rul L. Riveron Corteguera, Fisiopatología de la diarrea aguda, Hospital pediátrico docente de la Habana 2009
Results Reference
background
PubMed Identifier
10801944
Citation
King JC, Shames DM, Woodhouse LR. Zinc homeostasis in humans. J Nutr. 2000 May;130(5S Suppl):1360S-6S. doi: 10.1093/jn/130.5.1360S.
Results Reference
background
PubMed Identifier
12424162
Citation
Baqui AH, Black RE, El Arifeen S, Yunus M, Chakraborty J, Ahmed S, Vaughan JP. Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial. BMJ. 2002 Nov 9;325(7372):1059. doi: 10.1136/bmj.325.7372.1059.
Results Reference
background
PubMed Identifier
19876545
Citation
Fischer Walker CL, Fontaine O, Young MW, Black RE. Zinc and low osmolarity oral rehydration salts for diarrhoea: a renewed call to action. Bull World Health Organ. 2009 Oct;87(10):780-6. doi: 10.2471/blt.08.058990.
Results Reference
background
PubMed Identifier
20515554
Citation
Maggini S, Wenzlaff S, Hornig D. Essential role of vitamin C and zinc in child immunity and health. J Int Med Res. 2010 Mar-Apr;38(2):386-414. doi: 10.1177/147323001003800203.
Results Reference
background
Links:
URL
http://www.insp.mx
Description
Encuesta Nacional de Salud y Nutrición 2012
Learn more about this trial
Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute
We'll reach out to this number within 24 hrs